Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.19.3.a.u2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Dec. 31, 2019
Mar. 31, 2019
Current assets:    
Cash and cash equivalents $ 208,448  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 209,861 $ 207,918
Accounts receivable, net 142,007 154,059
Inventories, net 263,123 241,129
Prepaid expenses and other current assets 42,044 38,947
Total current assets 655,622 642,053
Noncurrent Assets:    
Property, plant and equipment, net of accumulated depreciation of $911,634 and $880,451 as of December 31, 2019 and March 31, 2019, respectively 548,594 495,280
Goodwill 40,294 40,294
Intangible assets, net 55,117 53,749
Equity method investments 16,641 12,925
Equity method investments 47,871 57,024
Other assets 48,193 16,770
Total assets 1,412,332 1,318,095
Current liabilities:    
Current portion of long-term debt 29,032 28,430
Accounts payable 111,465 153,287
Accrued expenses 130,991 93,761
Income taxes payable 3,981 2,995
Total current liabilities 275,469 278,473
Liabilities, Noncurrent [Abstract]    
Long-term debt 282,746 266,041
Other non-current obligations 153,025 125,360
Deferred Tax Liabilities, Net, Noncurrent 13,779 8,806
Liabilities 725,019 678,680
Stockholders’ equity:    
Preferred stock, par value $0.01, authorized 10,000 shares, none issued 0 0
Common stock, par value $0.01, authorized 175,000 shares, issued 58,267 and 57,822 shares at December 31, 2019 and March 31, 2019, respectively 583 578
Additional paid-in capital 471,641 465,366
Retained earnings (deficit) 240,074 204,195
Accumulated other comprehensive income (loss) (24,985) (30,724)
Total stockholders’ equity 687,313 639,415
Total liabilities and stockholders’ equity $ 1,412,332 $ 1,318,095